Condition

DLBCL (4)

Follicular Lymphoma (1)

Lymphoma (1)

Overall Status

Completed (3)

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 3 (1)

Sponsor

Rennes University Hospital (2)

The Lymphoma Academic Research Organisation (2)

Collaborator

CHU de Nancy (1)

Epizyme, Inc. (1)

French Innovative Leukemia Organisation (1)

National Cancer Institute, France (1)

Vanderbilt University (1)

Intervention

cyclophosphamide (1)

doxorubicin (1)

prednisolone (1)

rchop21 (1)

rituximab (1)

tazemetostat (1)

vincristine (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (4)

Study Type

Interventional (2)

Observational (2)

DLBCL

Showing NaN - NaN of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Lymphoma, DLBCL, Follicular Lymphoma Trial in Belgium, France (Tazemetostat, Rituximab, Cyclophosphamide)

Recruiting

Lymphoma
+2 more

Tazemetostat
+5 more

Bruxelles, Belgium
+30 more

Jul 23, 2021

DLBCL Trial in Belgium, France (RCHOP21)

Completed

DLBCL

RCHOP21

Antwerpen, Belgium
+82 more

Jul 10, 2020

SMOLY : Phenotype and Functions of Monocyte Subtypes in High

Completed

DLBCL

Rennes, Brittany, France

Rennes Univeristy Hospital

Nov 5, 2019

DNA Microarrays in Patients With Aggressive Lymphoma BMS_LyTrans

Completed

DLBCL

Amiens, France
+16 more

Apr 6, 2018